Informações:
Falhas:
ID
41145
Descrição
Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Phase II Randomized Control Clinical Trial; ODM derived from: https://clinicaltrials.gov/show/NCT02143388
Link
https://clinicaltrials.gov/show/NCT02143388
Palavras-chave
Versões (1)
- 30/06/2020 30/06/2020 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
30 de junho de 2020
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Local Advanced High Risk Nasopharyngeal Carcinoma NCT02143388
Eligibility Local Advanced High Risk Nasopharyngeal Carcinoma NCT02143388
- StudyEvent: Eligibility
Similar models
Eligibility Local Advanced High Risk Nasopharyngeal Carcinoma NCT02143388
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Nasopharyngeal carcinoma WHO tumor classification
Item
newly histologic diagnosis of nasopharyngeal carcinoma(who ii/iii)
boolean
C2931822 (UMLS CUI [1,1])
C1301142 (UMLS CUI [1,2])
C1301142 (UMLS CUI [1,2])
TNM clinical staging
Item
clinical stage iii~ivb(uicc 7th)
boolean
C3258246 (UMLS CUI [1])
Primary Neoplasm | SUV Maximum FDG-PET/CT | Tumor Volume | Cervical lymph nodes metastatic multiple | Cervical lymph node Diameter | TNM clinical staging | Epstein-Barr virus DNA Measurement
Item
meet at least one factor below :1 primary tumor suvmax>10 in 18f-fdg pet/ct;2 primary tumor volume＞30cm3;3 mutiple metastatic cervical lymph node with at least one's short diameter＞4cm; 4 t4n2m0; 5 t1-4n3m0;6 ebv-dna＞2×10e4 copy/l
boolean
C0677930 (UMLS CUI [1])
C2348529 (UMLS CUI [2,1])
C0806909 (UMLS CUI [2,2])
C4521453 (UMLS CUI [2,3])
C0475276 (UMLS CUI [3])
C0588054 (UMLS CUI [4,1])
C1522484 (UMLS CUI [4,2])
C0439064 (UMLS CUI [4,3])
C0588054 (UMLS CUI [5,1])
C1301886 (UMLS CUI [5,2])
C3258246 (UMLS CUI [6])
C0369169 (UMLS CUI [7,1])
C0242485 (UMLS CUI [7,2])
C2348529 (UMLS CUI [2,1])
C0806909 (UMLS CUI [2,2])
C4521453 (UMLS CUI [2,3])
C0475276 (UMLS CUI [3])
C0588054 (UMLS CUI [4,1])
C1522484 (UMLS CUI [4,2])
C0439064 (UMLS CUI [4,3])
C0588054 (UMLS CUI [5,1])
C1301886 (UMLS CUI [5,2])
C3258246 (UMLS CUI [6])
C0369169 (UMLS CUI [7,1])
C0242485 (UMLS CUI [7,2])
Age
Item
range from 18～70 years old
boolean
C0001779 (UMLS CUI [1])
White Blood Cell Count procedure | Hemoglobin measurement | Platelet Count measurement
Item
wbc count ≥ 4×109/l，hemoglobin ≥ 100g/l， platelet count ≥ 100×109/l
boolean
C0023508 (UMLS CUI [1])
C0518015 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0518015 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Serum total bilirubin measurement
Item
alt or ast ＜ 2.5×uln、bilirubin ＜ 1.5×uln
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C1278039 (UMLS CUI [3])
C0201899 (UMLS CUI [2])
C1278039 (UMLS CUI [3])
Creatinine measurement, serum
Item
oserum creatinine ＜ 1.5×uln
boolean
C0201976 (UMLS CUI [1])
CNS metastases
Item
central nervous system metastases
boolean
C0686377 (UMLS CUI [1])
Patients suitable Local Therapy
Item
suitable for local treatment
boolean
C0030705 (UMLS CUI [1,1])
C3900053 (UMLS CUI [1,2])
C1517925 (UMLS CUI [1,3])
C3900053 (UMLS CUI [1,2])
C1517925 (UMLS CUI [1,3])
Seizure Uncontrolled | Nervous system disorder Serious
Item
uncontrolled seizure disorder or other serious neurologic disease
boolean
C0036572 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0027765 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0205318 (UMLS CUI [1,2])
C0027765 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
Heart Disease | Respiration Disorder
Item
clinically significant cardiac or respiratory disease
boolean
C0018799 (UMLS CUI [1])
C0035204 (UMLS CUI [2])
C0035204 (UMLS CUI [2])
Substance Dependence
Item
drug or alcohol addition
boolean
C0038580 (UMLS CUI [1])
Legal capacity Limited
Item
do not have full capacity for civil acts
boolean
C0683673 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,2])
Severe medical complication | Communicable Disease
Item
severe complication, active infection
boolean
C3495031 (UMLS CUI [1])
C0009450 (UMLS CUI [2])
C0009450 (UMLS CUI [2])
Immunotherapy Disease Other | Hormone Therapy Disease Other
Item
concurrent immunotherapy or hormone therapy for other diseases
boolean
C0021083 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C0279025 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C0205394 (UMLS CUI [2,3])
C0012634 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C0279025 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C0205394 (UMLS CUI [2,3])
Pregnancy | Breast Feeding
Item
pregnancy or lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])